While SCFAs exert protective effects by strengthening the gut barrier and improving peripheral insulin sensitivity and glucose uptake, the dysregulated and excessive production of SCFAs may also negatively affect insulin sensitivity and disrupt glucose homeostasis, thereby leading to GDM [15]. Here, INS is linked to gestational diabetes.